Biomea Fusion, Inc. (BMEA)

1.30 -0.02 (-1.52%) USD  |  NASDAQ  |  Sep 28, 15:50
More

Biomea Fusion Cash from Operations (Annual) : -70.37M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for BMEA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -70.37M
December 31, 2024 -119.89M
December 31, 2023 -96.59M
December 31, 2022 -62.42M
Date Value
December 31, 2021 -35.44M
December 31, 2020 -4.459M
December 31, 2019 -1.279M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
REGENXBIO, Inc. -123.96M
Compass Therapeutics, Inc. -49.14M
ACADIA Pharmaceuticals, Inc. 109.84M
Alnylam Pharmaceuticals, Inc. 524.08M
Anika Therapeutics, Inc. 11.19M